HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Introduction of a programme for intravascular transfusions at severe rhesus isoimmunization.

Abstract
Thirty-seven fetuses with severe rhesus isoimmunization with a gestational age of less than 30 week underwent 92 intravascular transfusions. Of these, 77 were intracardiac, 13 umbilical vein and two umbilical artery transfusions. Procedure related complications occurred at eight (10%) intracardiac and at two (14%) umbilical cord transfusions. Reversal of hydrops was observed in 10 of 16 fetuses. The perinatal mortality among transfusion treated fetuses was 8/37 (21%). It is concluded that intravascular, intrauterine transfusion leads to improved results among fetuses with early onset of hydrops. Problems concerning indications and technique are discussed.
AuthorsM Westgren, F Jabbar, J F Larsen, F Rahman, A Selbing, M Stangenberg
JournalJournal of perinatal medicine (J Perinat Med) Vol. 16 Issue 5-6 Pg. 417-22 ( 1988) ISSN: 0300-5577 [Print] Germany
PMID3149303 (Publication Type: Journal Article)
Topics
  • Blood Transfusion, Intrauterine (adverse effects)
  • Female
  • Fetal Diseases (therapy)
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pregnancy
  • Pregnancy Outcome
  • Prenatal Care
  • Rh Isoimmunization (complications, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: